SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-008565
Filing Date
2015-02-12
Accepted
2015-02-12 19:18:13
Documents
1
Period of Report
2015-02-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v399541_3.html 3  
1 OWNERSHIP DOCUMENT v399541_3.xml 3 10542
  Complete submission text file 0001144204-15-008565.txt   12151
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BURNS & LEVINSON LLP 125 SUMMER STREET BOSTON MA 02110
Business Address C/O BURNS & LEVINSON LLP 125 SUMMER STREET BOSTON MA 02110 617-345-3000
IPSA (INNOVEN PARTENAIRES S.A.) (Reporting) CIK: 0001620376 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36672 | Film No.: 15608396